Team:Slovenia/Results/Engineered flagellin vaccine/Protein vaccine
From 2008.igem.org
|
|||
| |||
|
|||
A) ISOLATION AND CHARACTERIZATION OF CHIMERIC PROTEINS
Amino acid sequence of H. pylori FlaA was compared to those of other well known pathogenic bacteria. We found some differences in N -and C- terminal regions, which might prevent TLR5 binding or even actively inhibit TLR5-dependent innate immune response. Besides, flagellins in general have not only potent proinflammatory activity, but also play a role in triggering adaptive immune responses by stimulating chemokine secretion, migration and maturation of DCs, and by modulating T-cell activation. In this respect, we decided to construct a chimeric protein vaccine for the use in preventing and fighting chronic inflammatory and infectious diseases. Critical amino acid sequences of N- and C-terminal domain were determined based on the structure of Salmonella typhimurium flagellin. For successful TLR5 activation we decided to use N- and C-terminal conserved regions of E. coli flagellin FliC, and keep the hypervariable domain of H. pylori flagellin for optimal adaptive immune system activation. Chimeric flagellin was additionally fused to a H. pylori antigen, urease B or with a computationally constructed multiepitope, as outlined in detail in the Project section. At the end we added RGD tripeptide for better binding to integrins on M cells of the Peyer's patches and His-tag for Ni-NTA purification. Finally, alpha helix structure of chimeric flagellin was determined by CD spectroscopy.
|